Lonza Group Ag logo

Lonza Group Ag(OTC) LZAGF

Market Cap$50.96BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)+1,446%
5 Year-3%
1 Year+5%
1 Month+12%
$729.60
-0.03%
-0.20Today
Lonza Group Ag last closing stock price
MetricPriceDate
Last closeUSD 729.602026-10-16
Lonza Group Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+6.91%USD 682.452026-10-09
1 month+12.38%USD 649.212026-09-16
3 month+3.71%USD 703.512026-07-17
Year to date+8.35%USD 673.402025-12-31
1 year+5.13%USD 693.982025-10-16
3 year+89.39%USD 385.242023-10-17
5 year-2.91%USD 751.442021-10-15
Since inception+1,446.48%USD 47.182003-07-08

Lonza Group Ag Financials at a Glance

Market Cap

$50.96BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CHF 13.40B

Net Income (TTM)

CHF 1.80B

EPS (TTM)

-$1.77

P/E Ratio

-416.72

Dividend

$3.19

Beta (Volatility)

0.64 (Low)

Price

$729.60

Volume

486

Open

$717.81

Previous Close

$729.60

Daily Range

$702.54 - $745.42

52-Week Range

$565.14 - $755.96

Estimated Earnings Date

Jan 27, 2027

LZAGF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lonza Group Ag

Lonza Group AG, established in 1897 and headquartered in Basel, Switzerland, is a leading global provider of critical products and services for the pharmaceutical, biotechnology, and nutrition sectors. The company operates across multiple continents, delivering innovative solutions through its four primary divisions.

Products and Services
  • Biologics: Contract development and manufacturing of biopharmaceuticals
  • Small Molecules: Development and manufacturing of small molecule active pharmaceutical ingredients
  • Cell & Gene: Advanced technologies for cell and gene therapies
Growth Outlook
  • Revenue of CHF 3.36 billion in Q2 2026, reflecting strong demand
  • Operating income margin of 23.9% indicates efficient cost management
  • Continued investment in R&D to enhance product offerings and market reach
Financial Highlights
  • Net income of CHF 587.7 million in Q2 2026, showcasing profitability
  • Gross profit margin of 38.4% demonstrates strong pricing power
  • Debt ratio of 22.8% indicates a solid balance sheet and financial stability
Lonza Group AG is well-positioned in the biotechnology industry, leveraging its extensive experience and global reach to meet the growing needs of its clients. The company's focus on innovation and efficiency has resulted in impressive financial performance, with a notable increase in revenue and profitability in recent quarters. The strong operating income margin and healthy gross profit margin further underscore the company's ability to navigate market challenges effectively. With ongoing investments in research and development, Lonza is poised for continued growth, making it an attractive option for potential investors interested in the biotechnology sector.
AI Generated • Sep 28, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

16,866

CEO

Wolfgang Wienand, PhD

Website

www.lonza.com

Headquarters

Basel, BS 4002, CH

LZAGF Financials

Key Financial Metrics (TTM)

Gross Margin

36.53%

Operating Margin

24.57%

Net Income Margin

-1.74%

Return on Equity

-1.28%

Return on Capital

9.06%

Return on Assets

-0.60%

Earnings Yield

-0.24%

Dividend Yield

0.44%

Payout Ratio

-3.39%

Stock Overview

Market Cap

$50.96BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

69.84M

Volume

486

Avg. Volume

207.415

Financials (TTM)

Gross Profit

CHF 4.59B

Operating Income

CHF 2.50B

EBITDA

CHF 3.64B

Operating Cash Flow

CHF 2.59B

Capital Expenditure

-CHF 2.74B

Free Cash Flow

-CHF 157.42M

Cash & ST Invst.

CHF 487.00M

Total Debt

CHF 4.17B

Lonza Group Ag Performance Analysis

Lonza Group Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CHF 6,515,786,09010.1%
20232023-12-31CHF 7,474,530,58714.7%
20242024-12-31CHF 6,222,552,302-16.7%
20252025-12-31CHF 7,864,067,67926.4%
Lonza Group Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3115.0%
Q22025-06-301.7%
Q42025-12-31-17.3%
Q22026-06-3013.5%
Lonza Group Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CHF 17.11-60.4%
20232023-12-31CHF 9.88-42.3%
20242024-12-31CHF 10.132.6%
20252025-12-31CHF -4.73N/A
Lonza Group Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-6.5%
Q22025-06-3040.8%
Q42025-12-31-264.7%
Q22026-06-30184.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CHF 3.36B

+9.7%

Gross Profit

CHF 1.29B

+15.4%

Gross Margin

38.38%

N/A

Market Cap

$50.96BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.83M

N/A

Employees

17,995

N/A

Net Income

CHF 587.68M

+78.6%

EBITDA

CHF 1.14B

+34.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CHF 487.00M

-75.9%

Total Debt

CHF 4.17B

+9.8%

Accounts Receivable

CHF 1.92B

+23.8%

Inventory

CHF 1.88B

+9.7%

Long Term Debt

CHF 3.39B

-6.8%

Short Term Debt

CHF 774.00M

+399.4%

Return on Assets

-0.60%

N/A

Return on Invested Capital

11.04%

N/A

Free Cash Flow

CHF 80.54M

+168.8%

Operating Cash Flow

CHF 656.29M

+30.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,649.66-0.01%
^DJIDJI
$51,876.16-0.01%
^IXICNASDAQ
$26,111.34-0.02%
BTCBitcoin
$81,339.00-0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$89.85-5.79%
NVDANvidia
$214.13-1.43%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$93.67-12.74%
CCCCCC Intelligent Solutions
$7.61-0.26%

Questions About LZAGF

What is the current price of Lonza Group Ag?

Lonza Group Ag is trading at $729.60 per share.

What is the 52-week range for Lonza Group Ag?

Over the past 52 weeks, Lonza Group Ag has traded between $565.14 and $755.96.

How much debt does Lonza Group Ag have?

As of the most recent reporting period, Lonza Group Ag reported total debt of CHF 5.73B.

How much cash does Lonza Group Ag have on hand?

Lonza Group Ag reported CHF 907.54M in cash and cash equivalents in its most recent financial results.

What is Lonza Group Ag’s dividend yield?

Lonza Group Ag currently has a dividend yield of 0.44%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services